Utility of the 70-Gene MammaPrint Assay for Prediction of Benefit From Extended Letrozole Therapy in the NRG Oncology/NSABP B-42 Trial
Authors: Fehrenbacher, Louis | Journal Of Clinical Oncology : Official Journal Of The American Society Of Clinical Oncology | October 20, 2024 | PubMed abstract
